Process for preparation of compounds comprising 2, 5-dihydrobenzoxepin structure by photochemical rearrangement
The synthesis of 2,5-dihydro-1-benzooxoheptatriene compounds was simplified through ultraviolet radiation photochemical rearrangement reaction, solving the problems of multi-step and expensive metal catalysts in the prior art, and achieving high efficiency and rapidity synthesis is suitable for the preparation of biologically active compounds.
Patent Information
- Application Number
- CN202380021657.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-02-17
- Filing Date
- 2023-02-15
- Publication Date
- 2024-11-19
AI Technical Summary
In the prior art, the synthesis of compounds containing 2,5-dihydro-1-benzooxoheptatriene structure requires multiple steps, expensive metal catalysts and sensitive reagents, resulting in inefficiency and difficulty in achieving efficient, rapid and economical synthesis. .
The photochemical rearrangement reaction under ultraviolet radiation is adopted to perform ring expansion reactions under acid catalytic conditions through chromene precursors, which simplifies the synthesis route and avoids the use of expensive metal catalysts.
Achieve efficient and rapid synthesis of compounds with 2,5-dihydro-1-benzooxoheptatriene structures, which improves yield and reaction rate and reduces costs. It is suitable for the preparation of biologically active compounds such as radulanine A .
Smart Images

Figure BDA0004991229730000011 
Figure BDA0004991229730000012 
Figure BDA0004991229730000021
Abstract
Description
[0001] The present invention relates to the field of synthesis of compounds having a dihydrobenzoxepin structure. In particular, the present invention relates to a method for preparing a compound containing a 2,5-dihydro-1-benzoxepin structure from a compound having a chromene structure by photochemical rearrangement. The method is particularly suitable for preparing a dihydrobenzoxepin derivative having biological activity, especially herbicidal activity, from the corresponding chromene.
[0002] Benzoxepin or benzoxepin (benzooxepine) is composed of a benzene ring and an oxygen A bicyclic heterocyclic compound formed by fusion. Benzoxepin has three isomers, which can be represented by the following formula:
[0003] [Chemical formula 1]
[0004]
[0005] A compound having a dihydrobenzoxepin structure, also called a dihydrobenzoxepin derivative, is a compound in which one double bond of the oxepin is hydrogenated.
[0006] Benzoxepin derivatives generally exhibit biological activity and therefore constitute a family of compounds with various application values, especially in the pharmaceutical field, examples of which are, for example, the antidepressant doxepin, or in the field of phytopharmacology, examples of which are the herbicidal radulanine A and H. In particular, bibenzyl derivatives having a 2,5-dihydro-1-benzoxepin ring include the following structure:
[0007] [Chemical formula 2]
[0008]
[0009] Natural dihydrobenzoxepin compounds can be isolated from the mosses known as liverworts. These are allelopathic compounds known for their herbicidal activity. Among these compounds, particular mention should be made of the benzoxepin derivatives described in patent application FR 3 094 869, in particular radulanine A comprising the following formula:
[0010] [Chemical formula 3]
[0011]
[0012] Several synthetic routes to compounds containing the 2,5-dihydrobenzoxepin structure have been provided in the literature.
[0013] The first synthetic route uses a ruthenium complex-catalyzed cycloolefin metathesis reaction to condense 2,5-dihydrooxadenosine. The double bond of the ring (M. Yoshida et al., Tetrahedron, 2009, 65, 5702-5708), the specific scheme is as follows:
[0014] [Chemical formula 4]
[0015]
[0016] The second synthetic route uses Mitsunobu reaction to form a cyclic ether linker (S. Yamaguchi et al., Tetrahedron Letters, 2000, 41, 4787-4790), and the specific scheme is as follows:
[0017] [Chemical formula 5]
[0018]
[0019] The third synthetic route uses a retro-Claisen-type rearrangement reaction starting from a vinyl cyclopropane precursor (W. Zhang et al., Chem. Eur. J., 2019, 25, 8643-8648), followed by aromatization, as follows:
[0020] [Chemical formula 6]
[0021]
[0022] These synthetic routes take a long time to implement, since obtaining the radulanine precursors usually requires many steps to carry out reactions that are difficult to carry out, either because of the sensitivity of the reagents involved or because of the use of expensive metals as catalysts, such as ruthenium. As a result, none of these reactions can be used for the efficient, rapid and economical synthesis of radulanin, or more generally of compounds containing the 2,5-dihydro-1-benzoxepin structure.
[0023] Therefore, it is desirable to provide a process for obtaining compounds having a 2,5-dihydrobenzoxepin structure economically, ie requiring only a few steps and without using expensive metals.
[0024] Therefore, the object of the present invention is to overcome the disadvantages of the prior art and provide a method for synthesizing a compound having a 2,5-dihydrobenzoxepin structure.
[0025] Therefore, the object of the present invention is to provide a method for synthesizing a compound of the following formula (I):
[0026] [Chemical formula 7]
[0027]
[0028] in:
[0029] -R 1 Represents hydrogen atom or C 1 -C 6 alkyl,
[0030] -R 2 , R 3 and R 4 Each independently represents a hydrogen atom, a halogen atom, a C 1 To C 5 Alkyl or cycloalkyl, or selected from -OH, -COOH, -COOR 6 、-OR 6 and-SO 2 R 6 A group in which R 6 C 1 To C 5 Alkyl or cycloalkyl, the C 1 To C 5 The alkyl or cycloalkyl group may be substituted with one or more substituents selected from halogen atoms and hydroxyl groups;
[0031] -R 5 Represents hydrogen atoms, halogen atoms, C 1 To C 5 Alkyl or cycloalkyl, or selected from -OH, -COOH, -COOR 6 、-OR 6 and-SO 2 R 6 A group in which R 6 C 1 To C 5 Alkyl or cycloalkyl, the C 1 To C 5 The alkyl or cycloalkyl group may be substituted with one or more substituents selected from halogen atoms and hydroxyl groups, or R 5 represents the group -LA, in which:
[0032] *L represents a bond arm selected from linear and branched alkylene chains having at least one carbon atom, which linear or branched alkylene chains may be interrupted and / or terminated by one or more heteroatoms selected from oxygen, sulfur or substituted nitrogen atoms, and
[0033] *A represents an aromatic group selected from phenyl, naphthyl, furanyl, thienyl, pyrrolyl, pyridyl, indolyl, isoindolyl, benzofuranyl, benzothienyl, quinolyl, isoquinolyl, imidazolyl, oxazolyl, thiazolyl, pyrimidinyl, pyridazyl, pyrazinyl, pyrazolyl and triazolyl, and the aromatic group A can be selected from halogen atoms, C 1 To C 5 Alkyl or cycloalkyl, -OH group, -COOH group, -COOR 7 Group, -OR 7 Groups and -SO 2 R 7 A group is substituted with one or more substituents, wherein R 7 C 1 To C 5 Alkyl or cycloalkyl, the C 1 To C 5 The alkyl or cycloalkyl group may be substituted with one or more substituents selected from halogen atoms and hydroxyl groups, or with one of their organic or inorganic salts, and wherein
[0034] -R 2 , R 3 , R 4 and R 5 At least one of the groups represents a -OH group,
[0035] Characterized in that the method comprises the step of irradiating a solution of a compound of the following formula (II) in a solvent with ultraviolet radiation:
[0036] [Chemical formula 8]
[0037]
[0038] Where R 1 , R 2 , R 3 , R 4 and R 5 has the same meanings as for the compounds of formula (I) shown above.
[0039] Therefore, the method according to the present invention realizes the ring expansion reaction of compounds containing 2-methylchromene structure, preferably 2-alkyl-2-methylchromene structure, most preferably 2,2-dimethylchromene structure, which reaction is carried out under photochemical conditions. The chromene precursor can be synthesized from phenol and α,β-unsaturated aldehyde in several steps using acid catalysis.
[0040] In the above formula (I) and formula (II), R 1 The alkyl group represented by may be straight-chain or branched and is preferably selected from the group comprising methyl, ethyl and tert-butyl, and is particularly preferably methyl.
[0041] As examples of inorganic salts of compounds of formula (I), mention may be made of alkali metal salts and alkaline earth metal salts of compounds of formula (I).
[0042] As examples of organic salts of compounds of formula (I), mention may be made of the ammonium salts of compounds of formula (I).
[0043] In the present invention, the C 1 To C 5 The alkyl group or cycloalkyl group may be linear or branched, and is preferably linear.
[0044] For the purposes of the present invention, halogen is selected from F, Cl, Br and I, preferably from F and Cl.
[0045] R 2 , R 3 , R 4 and R 5 Definition of
[0046] As the group R 2 , R 3 , R 4 or R 5 The alkyl or cycloalkyl group is preferably an alkyl group, particularly preferably a straight-chain alkyl group, and more particularly preferably a C 1 To C 3 Straight chain alkyl.
[0047] As the group R 6 The alkyl or cycloalkyl group is preferably an alkyl group, particularly preferably a straight-chain alkyl group, and more particularly preferably a C 1 To C 3 Straight chain alkyl.
[0048] As the group R 2 , R 3 , R 4 or R 5 The alkyl or cycloalkyl group may be substituted with one or more substituents selected from halogen atoms and hydroxyl groups.
[0049] According to a particularly preferred embodiment of the invention, the group R 2 , R 3 , R 4 or R 5 At least one of represents an -OH group. In this case, the at least one hydroxyl group is preferably in the 6th position.
[0050] In this embodiment, the other two groups R 2 , R 3 , or R 2 and R 3 or R 3 and R 4 represents hydrogen atom, R 5 Representative group -LA.
[0051] Definition of L
[0052] L preferably represents a linear or branched alkylene chain having 1 to 6 carbon atoms, particularly preferably a linear alkylene chain having 2 to 3 carbon atoms, very particularly preferably a linear alkylene chain having 2 carbon atoms.
[0053] The straight or branched alkylene chain as bonding arm L may be interrupted and / or terminated by one or more heteroatoms selected from oxygen, sulfur and substituted nitrogen atoms, preferably by one or more oxygen atoms.
[0054] Nitrogen can be transported via C 1 To C 5 , preferably C 1 To C 3 The alkyl group is preferably a straight-chain alkyl group.
[0055] Definition of A
[0056] The alkyl or cycloalkyl group as a substituent of the group A is preferably an alkyl group, particularly preferably a straight-chain alkyl group, more particularly a C 1 To C 3 Straight chain alkyl.
[0057] As the group R 7 The alkyl or cycloalkyl group is preferably an alkyl group, particularly preferably a straight-chain alkyl group, more particularly a C 1 To C 3 Straight chain alkyl.
[0058] As the group A and the group R 7 The alkyl or cycloalkyl group may be substituted with one or more substituents selected from halogen atoms and hydroxyl groups.
[0059] A preferably represents an aryl group selected from phenyl, naphthyl and pyridyl, particularly preferably an aromatic group of phenyl.
[0060] The method of the invention can be performed in static mode or in continuous throughput.
[0061] According to a first embodiment, the process can be carried out in static mode. This first embodiment makes it possible to obtain conversions of the compound of formula (II) ranging from 90% to 100%, with yields of the compound of formula (I) ranging from about 10% to 50%.
[0062] According to this first embodiment, the method of the invention is carried out in an immersion tank equipped with a tube transparent to UV radiation, for example made of Pyrex, immersed and cooled in ice water containing a UV lamp.
[0063] According to a second embodiment, the method can be carried out under continuous flux. This second embodiment can improve reaction rate, reproducibility and the productive rate of the compound comprising formula (I) structure. In this case, the transformation efficiency of the starting compound of formula (II) can be 90% to 100%, and the productive rate of the compound comprising formula (I) structure is about 30% to 50%. This second embodiment is preferred.
[0064] According to this second embodiment, the method is carried out in a continuous flux reactor consisting of a tube transparent to UV radiation, for example made of a thermoplastic material such as perfluoroalkoxyalkane (PFA). The tube is wound around a UV lamp equipped with a Pyrex type filter. A degassed solution of the compound of formula (II) is injected into the reactor in a continuous flux, in particular, its flow rate may be from 0.5 ml / min to 2 ml / min.
[0065] The solvent of the solution can be selected from aromatic hydrocarbons (such as benzene and toluene), acetonitrile and ethyl acetate. Among these solvents, acetonitrile and ethyl acetate are preferred, and acetonitrile is particularly preferred.
[0066] The duration of the irradiation step is generally about 5 minutes to 5 hours.
[0067] According to a first embodiment of the invention, the process is carried out in static mode and the duration of the irradiation step is between 1 hour and 5 hours, preferably between 1 hour and 2 hours.
[0068] According to a second embodiment of the invention, the process is carried out under continuous flux and the duration of the irradiation step is between 5 and 20 minutes, preferably between 8 and 12 minutes.
[0069] According to the present invention, ultraviolet radiation refers to any invisible radiation emitted in the wavelength range of 100 nanometers (nm) to 400 nm.
[0070] According to a preferred embodiment of the present invention, the irradiation step is performed at a wavelength of about 200 nm to 400 nm, and even more preferably at a wavelength of about 250 nm to 350 nm.
[0071] UV radiation is usually generated by ultraviolet (UV) emitting lamps. According to the invention, it is preferred to use medium-pressure mercury UV lamps with a power of about 100 W to 400 W, preferably about 150 W.
[0072] According to the present invention and by definition, "medium pressure" means a pressure of about 1×10 5 Pascal to 1×10 6 Pascal.
[0073] According to a particularly preferred embodiment of the present invention, the process is carried out for the preparation of a compound of the following formula (Ia):
[0074] [Chemical formula 9]
[0075]
[0076] Where R 1 , R 2 , R 3 , R 4 , A and L have the same meanings as for the compound of formula (I) as shown above. In this case, the compound of formula (II) after the irradiation step has the following formula (IIa):
[0077] [Chemical formula 10]
[0078]
[0079] Where R 1 , R 2 , R 3 , R 4 , A and L have the same meanings as in the compound of formula (I) shown below.
[0080] Preferably, in the compounds of formula (Ia), the group R 2 , R 3 and R 4 At least one of represents an -OH group. In this case, the at least one hydroxyl group is preferably in position 6. It is also particularly preferred that the group -LA is in position 8, L represents an ethylene chain and A is a benzene ring.
[0081] According to a particularly preferred embodiment of the present invention, the process is carried out for the preparation of radulanine A of the following formula (Ia-1):
[0082] [Chemical formula 11]
[0083]
[0084] Thus, radulanine A corresponds to a compound of formula (Ia) wherein R 1 Represents methyl, group R 2 , R 3 and R 4 One of them represents the OH group at position 6, and the other two groups R 2 and R 3 , R 3 and R 4 , represent hydrogen atoms, R 5 It is a group -LA located at the 8th position, and A is a benzene ring.
[0085] Various synthetic methods can be used to provide chromenes of formula (II). Such methods are described in particular in R. Pratap et al., Chem. Rev, 2014, 114, 10476-10526.
[0086] In particular, when the process is carried out for the preparation of a compound of formula (I), wherein R 1 and R 5 As defined in formula (I), the group R 2 , R 3 and R 4 One of them represents the OH group at position 6, and the other two groups R 2 and R 3 , R 3 and R 4 , respectively represent a hydrogen atom (compound of formula (I')), and then the corresponding chromene of formula (II) (chromene of formula (II')) is preferably obtained by condensing a diphenol of formula (III), , and an α,β-unsaturated aldehyde of formula (IV), wherein R 5 has the same meaning as in formula (I), R 1 has the same meaning as in formula (I), according to the following reaction scheme:
[0087] [Chemical formula 12]
[0088]
[0089] According to the method described by Lee et al. (Tetrahedron Lett. 2005, 46, 7539-7543), in the presence of an acidic catalyst such as ethylenediaminediacetic acid (EDDA), or in the presence of a Lewis acid such as Yb(OTf) 3 、ZnCl 2 In the presence of Brønsted acids such as ammonium acetate (NH 4 OAc), trifluoroacetic acid (TFA) or acetic acid (AcOH); in the presence of a solvent, in a closed reactor (e.g., a sealed tube), under reflux and an inert atmosphere.
[0090] When the precursors of formula (III) and formula (IV) are not commercially available, they can be synthesized according to conventional methods. For example, unsaturated aldehydes can be obtained by Horner-Wadsworth-Emmons type olefination reaction of carbonyl derivatives with triethyl phosphonoacetate, followed by reduction of the ester group to the aldehyde. Phenolic derivatives can be obtained by various methods of electrophilic aromatic substitution reactions well known to those skilled in the art, or by cross-coupling of reactive derivatives, or even by functionalizing groups already present in the aromatic system.
[0091] The reaction solvent may be selected from toluene, xylene, benzene, dichloromethane and acetic acid.
[0092] Other characteristics, alternatives and advantages of the method according to the invention will become more apparent on reading the following exemplary embodiments, which are intended to illustrate and not limit the invention. Example
[0093] Toluene, acetonitrile and benzene were distilled from calcium hydride before use and, if necessary, degassed by bubbling with nitrogen.
[0094] Thin layer chromatography (TLC) was performed on silica gel (Silica gel 60, F254, Merck) on aluminum plates and visualization was performed by exposure to UV light and / or exposure to alkaline potassium permanganate solution or p-anisaldehyde staining solution followed by heating.
[0095] Flash column chromatography was performed on silica gel 60 (40 μm to 63 μm).
[0096] Nuclear magnetic resonance spectroscopy ( 1 H NMR and 13 C NMR) were measured at 25 °C using a Bruker Avance 400 spectrometer (400 MHz, 1 H at 400MHz, 13 C NMR was recorded at 100 MHz using CDCl 3 As solvent, refer to the residual CHCl 3 (δH=7.26 ppm, δC=77.1 ppm) Chemical shifts are in ppm and coupling constants (J) are in Hertz. 1 H NMR spectral data are reported as follows: chemical shift in ppm (brs = broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, dd = double of doublet, td = double of triplet, ddd = double of doublets, m = multiplet, coupling constant, integral).
[0097] Infrared spectra were recorded on a PerkinElmer FTIR spectrometer using the attenuated total reflectance (ATR) technique. max ) in wavenumber (cm -1 )express.
[0098] High-resolution mass spectra (HRMS) have been acquired on a JEOL JMS-GCmate II spectrometer and are reported as m / z.
[0099] Batch photochemical experiments in static mode were performed in 500 mL immersion cells or 10 mL Pyrex sealed tubes, irradiated with a 150 W medium pressure Hg Heraeus lamp.
[0100] Flux photochemistry experiments were performed on a Vapourtec E-series system equipped with a UV-150 photoreactor fitted with a medium pressure Hg lamp (75 W to 150 W) used in conjunction with a Pyrex filter.
[0101] Example 1: Synthesis of radulanine A (compound of formula Ia-1) according to the method of the present invention
[0102] Radulanine A has been prepared according to the process of the present invention which implements the photochemical rearrangement step in continuous flux according to the steps shown in the following scheme:
[0103] [Chemical formula 13]
[0104]
[0105] 1.1 Step 1: Preparation of (E)-3,5-dimethoxyphenylethylene (Compound 3)
[0106] The first step is the Horner-Wadsworth-Emmons reaction. Under an inert atmosphere, potassium tert-butyrate (t-BuOK) (10.8 g, 96.3 mmol) and anhydrous tetrahydrofuran (THF) (120 mL) are added to a flame-dried 500 mL flask equipped with a magnetic stirrer. The mixture is cooled in an ice bath, and then diethyl phenylphosphonate (Compound 1) (20.6 mL, 90.3 mmol) is added dropwise over 30 minutes, followed by 3,5-dimethoxybenzaldehyde (Compound 2) (10.0 g, 60.2 mmol). The mixture is warmed to room temperature and then stirred for 2 h. THF is removed in vacuo, and then a mixture of water and methanol (H 2 O:MeOH) (2:1, about 60 mL) was added until the product precipitated. Filtration and vacuum drying gave (E)-3,5-dimethoxystilbene (Compound 3) as a white solid (13.5 g, 56.0 mmol, 93% yield).
[0107] 1 H NMR (400 MHz, CDCl 3 ): δ=7.53-7.49(m,2H),7.39-7.33(m,2H),7.29-7.23(m,1H),7.09(d,J=16.3Hz,1 H), 7.04 (d, J = 16.3Hz, 1H), 6.69-6.66 (m, 2H), 6.40 (t, J = 2.3Hz, 1H), 3.83 (s, 6H).
[0108] 1.2 Second step: Preparation of 1,3-dimethoxy-5-phenylethylbenzene (Compound 4)
[0109] The second step is the double bond catalytic hydrogenation reaction implemented by ammonium formate. Therefore it avoids the use of hydrogen. (E)-3,5-dimethoxystilbene (14.0g, 58.2 mmoles) and 10% Pd / C (1.40g, 10wt%) prepared in the previous steps are then added to ethyl acetate (243mL, 0.245M) through flame drying 500mL flask. Then ammonium formate (18.4g, 291 mmoles) is added, and the mixture is stirred at room temperature overnight. Then the reaction mixture is filtered and evaporated in vacuo by diatomaceous earth pad. The residual ammonium formate is precipitated by adding dichloromethane, and the mixture is filtered and evaporated in vacuo again, and expected 1,3-dimethoxy-5-phenylethylbenzene (compound 4) is obtained, which is a light yellow oil (12.7g, 52.4 mmoles, 90% yield).
[0110] 1 H NMR (400 MHz, CDCl 3 ): b=7.32-7.25(m,2H),7.23-7.17(m,3H),6.36-6.30(m,3H),3.76(s,6H),2.95-2.82(m,4H).
[0111] 1.3. The third step: preparation of dihydropyrrolidone (compound 5)
[0112] The third step is the demethylation of phenol in an acidic aqueous medium. 1,3-dimethoxy-5-phenylethylbenzene (2.03 g, 8.38 mmol) prepared in the previous step was added to a 250 mL flask equipped with a magnetic stirrer, followed by hydrobromic acid (HBr) (24.6 mL, 48 wt% in water) and glacial acetic acid (24.6 mL, HBr: AcOH volume ratio of 1:1, final concentration 0.15 M). The reaction mixture was then heated to reflux for 4 h and cooled to room temperature. The reaction mixture was diluted with water (50 mL) and ethyl ether (Et 2 The organic phase was treated with activated charcoal, filtered and concentrated in vacuo to afford dihydropyrrolidine as a white solid (1.68 g, 7.86 mmol, 94%).
[0113] 1 H NMR (400 MHz, CDCl 3 ): δ=7.33-7.25(m,2H),7.24-7.15(m,3H),6.31-6.18(m,3H),4.71(br s,2H),2.93-2.75(m,4H).
[0114] 1.4 Step 4: Preparation of 2,2-dimethyl-7-phenylethyl-2H-chromen-5-ol (Compound 6)
[0115] Under an inert atmosphere, dihydropyropine (4.00 g, 18.7 mmol-1 equivalent) obtained in the previous step was added to a flame-dried sealed tube equipped with a magnetic stirrer, followed by anhydrous toluene (0.1 M) and 3-methyl-2-butenal (isopentenal) (1.5 equivalents). Ethylenediaminediacetic acid (EDDA, 5 mol%) was then added. The container was sealed and heated to 115°C and kept for 1 h. This process (EDDA addition and heating) was repeated 3 times (a total of 15 mol% EDDA was added), and then after returning to room temperature, a small amount of silica was added and the solvent was removed under vacuum. The crude mixture was purified by flash silica column chromatography (dry loading) and eluted with hexane / ethyl acetate to obtain the expected 2,2-dimethyl-7-phenethyl-2H-chromene-5-ol (compound 6) as a viscous brown liquid (4.28 g, 15.3 mmol, 82% yield).
[0116] 1 H NMR (400 MHz, CDCl 3 ): δ=7.31-7.24(m,2H),7.22-7.15(m,3H),6.58(d,J=10.0,1H),6.32-6.29(m,1H),6.14-6.10(m,1H),5.55(d,J=10.0,1H),4.59(br s,1H),2.92-2.83(m,2H),2.80-2.73(m,2H),1.42(s,6H).
[0117] 1.5. Fifth step: Preparation of radulanine A (compound (Ia-1)) by photochemical rearrangement under continuous flux
[0118] Under nitrogen atmosphere, a solution of compound 6 (200 mg, 0.713 mmol) obtained in the previous step was prepared in anhydrous acetonitrile (713 mL, 0.001 M) degassed with nitrogen and placed in a flame-dried 1 L flask. The continuous flux system was first rinsed with degassed anhydrous acetonitrile, and then the solution of compound 6 was injected into a photochemical reactor equipped with a Pyrex filter, with a lamp power of 100% (150 W), a flow rate of 1.2 ml / min (residence time in the reactor was 8.44 minutes), a pressure of 300 KPa, and a reactor temperature of 30° C. The collected solution was evaporated in vacuo, and the crude mixture was purified by flash column chromatography, eluting with 2% to 10% EtOAc: hexane to obtain radulanine A (compound of formula (Ia-1)) as a brown oil (52.2 mg, 0.186 mmol, 26%).
[0119] The NMR analysis of Rradulanine A is as follows: 1 H NMR (400 MHz, CDCl 3): δ = 7.32-7.24 and 7.22-7.14 (m, 5H), 6.53 (d, J = 1.5 Hz, 1H), 6.37 (d, J = 1.5 Hz, 1H), 5.64-5.57 (m, 1H), 4.84 (br s, 1H), 4.44-4.37 (m, 2H), 3.44-3.34 (m, 2H), 2.91-2.83 and 2.83-2.75 (m, 4H), 1.57-1.50 (m, 3H).
[0120] Example 2: Synthesis of radulanine A (compound of formula Ia-1) in static mode according to the method of the present invention
[0121] Radulanine A was prepared according to the same procedure as the synthetic scheme in Example 1 above, but the fifth photochemical rearrangement step was carried out in static mode.
[0122] Under an inert atmosphere, compound 5 (2.70 mg, 0.00963 mmol) prepared in step 4 of Example 1 above and dry, degassed benzene (9.00 mL, 0.001 M) were added to a flame-dried 10 mL Pyrex sealed tube equipped with a magnetic stirrer. The tube was directly connected to the cooling jacket of a 150 W medium pressure mercury lamp. The reaction mixture was irradiated for 1 h with stirring. The solvent was evaporated in vacuo and the crude reaction mixture was purified by 1 H NMR analysis showed that compound 5 was completely converted into radulanine A.
[0123] 1 H NMR (400 MHz, CDCl 3 ): δ = 7.32-7.24 and 7.22-7.14 (m, 5H), 6.53 (d, J = 1.5 Hz, 1H), 6.37 (d, J = 1.5 Hz, 1H), 5.64-5.57 (m, 1H), 4.84 (br s, 1H), 4.44-4.37 (m, 2H), 3.44-3.34 (m, 2H), 2.91-2.83 and 2.83-2.75 (m, 4H), 1.57-1.50 (m, 3H).
[0124] Example 3: Synthesis of 3,8-dimethyl-2,5-dihydrobenzoxepin-6-ol (compound of formula I-1) in static mode according to the method of the present invention
[0125] 3,8-Dimethyl-2,5-dihydrobenzoxepin-6-ol has been prepared according to the process of the present invention, which implements the photochemical rearrangement step in continuous flux according to the steps shown in the following scheme:
[0126] [Chemical formula 14]
[0127]
[0128] 3.1 Step 1: Preparation of 2,2,7-trimethyl-2H-chromen-5-ol (Compound 7)
[0129] Under an inert atmosphere, orcinol (1 eq.) was added to a flame-dried sealed tube equipped with a magnetic stirrer, followed by anhydrous toluene (0.1 M) and isopentanal (1.5 eq.). Ethylenediaminediacetic acid (EDDA, 5 mol%) was then added. The vessel was sealed and heated to 115°C for 1 h. This process (addition and heating of EDDA) was repeated 3 times (a total of 15 mol% EDDA was added), then after returning to room temperature, a small amount of silica was added and the solvent was removed under vacuum. The crude mixture was purified by flash silica column chromatography (dry loading) eluting with hexane / EtOAc to give the desired 2,2,7-trimethyl-2H-chromene-5-ol (Compound 7).
[0130] 1 H NMR (400 MHz, CDCl 3 ): δ=6.57(d,J=10.0,1H),6.26-6.24(m,1H),6.14-6.11(m,1H),5.53(d,J=10.0Hz,1H),4.60(br s,1H),2.22-2.20(m,3H),1.41(s,6H).
[0131] 3.2. Second step: 3,8-dimethyl-2,5-dihydrobenzoxepin-6-ol (compound of formula I-1) Preparation
[0132] Under inert atmosphere, compound 7 (75 mg, 0.394 mmol) obtained in the previous steps and anhydrous benzene (250 mL, 0.00158 M) degassed with nitrogen bubbling were added to a 500 mL immersion tank equipped with a 150 W mercury lamp, a water-cooled jacket and a magnetic stirrer. The reaction mixture was stirred and irradiated for 30 minutes and then cooled. This process was repeated 10 times until the mixture was irradiated for a total of 5 hours. The reaction mixture was then evaporated in vacuo in a flask, and the crude mixture was purified by flash column chromatography with 1:1 hexane:CH 2 Cl 2 Elution afforded the expected compound of formula (Ia-1) as a yellow oil (35.3 mg, 0.185 mmol, 47%).
[0133] Rf = 0.19 (1:1 hexane / CH 2 Cl 2 )
[0134] 1 H NMR (400 MHz, CDCl 3): δ=6.50-6.52(m,1H),6.39-6.36(m,1H),5.65-5.57(m,1H),4.80(br s,1H),4.44-4.37(m,2H),3.43-3.36(m,2H),2.25-2.23(m,3H),1.56-1.51(m,3H).
[0135] 13 C NMR (101 MHz, CDCl 3 ): δ=159.7,152.0,137.4,134.0,120.7,120.1,114.5,112.2,74.3,21.6,21.0,20.1.
[0136] IR(ATR): 3350, 2931, 1715, 1619, 1583, 1450, 1378, 1311, 1207, 1068, 986, 836, 753.
[0137] HRMS(EI+):C 12 H 15 O 2 + Calculated value: 191.1067; Received value: 191.1064.
Claims
1. A method for synthesizing a compound of the following formula (I): [Chemical formula 15] in: -R 1 Represents hydrogen atom or C 1 -C 6 alkyl, -R 2 , R 3 and R 4 Each independently represents a hydrogen atom, a halogen atom, a C 1 To C 5 Alkyl or cycloalkyl, or selected from -OH, -COOH, -COOR 6 、-OR 6 and-SO 2 R 6 A group in which R 6 C 1 To C 5 Alkyl or cycloalkyl, the C 1 To C 5 The alkyl or cycloalkyl group may be substituted with one or more substituents selected from halogen atoms and hydroxyl groups; -R 5 Represents hydrogen atoms, halogen atoms, C 1 To C 5 Alkyl or cycloalkyl, or selected from -OH, -COOH, -COOR 6 、-OR 6 and-SO 2 R 6 A group in which R 6 C 1 To C 5 Alkyl or cycloalkyl, the C 1 To C 5 The alkyl or cycloalkyl group may be substituted with one or more substituents selected from halogen atoms and hydroxyl groups, or R 5 represents a -LA group, wherein: *L represents a bond arm selected from linear and branched alkylene chains having at least one carbon atom, which linear or branched alkylene chains may be interrupted and / or terminated by one or more heteroatoms selected from oxygen, sulfur or substituted nitrogen atoms, and *A represents an aromatic group selected from phenyl, naphthyl, furanyl, thienyl, pyrrolyl, pyridyl, indolyl, isoindolyl, benzofuranyl, benzothienyl, quinolyl, isoquinolyl, imidazolyl, oxazolyl, thiazolyl, pyrimidinyl, pyridazinyl, pyrazinyl, pyrazolyl and triazolyl, and the aromatic group A can be selected from halogen atoms, C 1 To C 5 Alkyl or cycloalkyl, -OH group, -COOH group, -COOR 7 Group, -OR 7 Groups and -SO 2 R 7 A group is substituted with one or more substituents, wherein R 7 C 1 To C 5 Alkyl or cycloalkyl, the C 1 To C 5 The alkyl or cycloalkyl group may be substituted with one or more substituents selected from halogen atoms and hydroxyl groups, or with one of their organic or inorganic salts, and wherein -R 2 , R 3 , R 4 and R 5 At least one of the groups represents a -OH group, Characterized in that the method comprises the step of irradiating a solution of a compound of the following formula (II) in a solvent with ultraviolet radiation: [Chemical formula 16] Where R 1 , R 2 , R 3 , R 4 and R 5 has the same meanings as the compounds of formula (I) as shown below.
2. The method according to claim 1, It is characterized in that The solvent of the solution is selected from aromatic hydrocarbons, acetonitrile and ethyl acetate.
3. The method according to any one of claims 1 to 3, It is characterized in that The method is carried out in static mode and the duration of the irradiation step is between 1 hour and 5 hours.
4. The method according to any one of claims 1 to 3, It is characterized in that The method is performed in continuous flux.
5. The method according to claim 4, It is characterized in that The duration of the irradiation step is between 5 minutes and 20 minutes.
6. The method according to any one of the preceding claims, It is characterized in that The irradiating step is performed at a wavelength of 250 nm to 350 nm.
7. The method according to any one of the preceding claims, It is characterized in that The at least one hydroxyl group is located at the 6th position.
8. The method according to any one of the preceding claims, It is characterized in that The other two groups R 2 , R 3 , or R 2 and R 4 , or R 3 and R 4 represents hydrogen atom, R 5 Representative group -LA.
9. The method according to any one of the preceding claims, It is characterized in that L represents a linear alkylene chain having 2 to 3 carbon atoms.
10. The method according to any one of the preceding claims, It is characterized in that A represents an aromatic group selected from phenyl, thienyl and pyridyl.
11. The method according to any one of the preceding claims, It is characterized in that The process is carried out to prepare the compound of formula (Ia): [Chemical formula 17] Where R 1 , R 2 , R 3 , R 4 , A and L have the same meanings as those shown for the compound of formula (I), and the compound of formula (II) after the irradiation step corresponds to the following formula (IIa): [Chemical formula 18] Where R 1 , R 2 , R 3 , R 4 , A and L have the same meanings as shown in the compound of formula (I).
12. The method according to claim 11, It is characterized in that The group LA is located at the 8th position, L represents an ethylene chain, and A is a benzene ring.
13. The method according to claim 11 or 12, It is characterized in that The method is carried out to prepare radulanine A of the following formula (Ia-1): [Chemical formula 19]
